Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs Instituut voor Tropische Geneeskunde Universiteit Antwerpen
New drugs are needed to control leishmaniasis and efforts are currently ongoing to counter the neglect of this disease. We discuss here the utility and the impact of associating drug resistance (DR) studies to drug discovery pipelines. We use as paradigm currently used drugs, antimonials and miltefosine, and complement our reflection by interviewing three experts in the field. We suggest DR studies to be involved at two different stages of ...